ATP-citrate lyase as a therapeutic target in chronic kidney disease: a Mendelian Randomization analysis
Pedrum Mohammadi-Shemirani, Michael Chong, Nicolas Perrot, Marie Pigeyre, Gregory R. Steinberg, View ORCID ProfileGuillaume Paré, Joan C. Krepinsky, View ORCID ProfileMatthew B. Lanktree
doi: https://doi.org/10.1101/2021.10.07.21264710
Pedrum Mohammadi-Shemirani
1Population Health Research Institute, Hamilton, Ontario, Canada
2Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada
3Department of Medical Sciences, McMaster University, Hamilton, Ontario, Canada
Michael Chong
1Population Health Research Institute, Hamilton, Ontario, Canada
2Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada
3Department of Medical Sciences, McMaster University, Hamilton, Ontario, Canada
Nicolas Perrot
1Population Health Research Institute, Hamilton, Ontario, Canada
Marie Pigeyre
1Population Health Research Institute, Hamilton, Ontario, Canada
4Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Gregory R. Steinberg
4Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
5Centre for Metabolism, Obesity, and Diabetes Research, McMaster University, Hamilton, Ontario, Canada
6Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada
Guillaume Paré
1Population Health Research Institute, Hamilton, Ontario, Canada
2Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada
7Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
8Department of Health Research Methods, Evidence & Impact, McMaster University, Hamilton, Ontario, Canada
Joan C. Krepinsky
5Centre for Metabolism, Obesity, and Diabetes Research, McMaster University, Hamilton, Ontario, Canada
9Division of Nephrology, Department of Medicine, McMaster University and St. Joseph Healthcare Hamilton, Hamilton, Ontario, Canada
Matthew B. Lanktree
1Population Health Research Institute, Hamilton, Ontario, Canada
8Department of Health Research Methods, Evidence & Impact, McMaster University, Hamilton, Ontario, Canada
9Division of Nephrology, Department of Medicine, McMaster University and St. Joseph Healthcare Hamilton, Hamilton, Ontario, Canada
Posted October 11, 2021.
ATP-citrate lyase as a therapeutic target in chronic kidney disease: a Mendelian Randomization analysis
Pedrum Mohammadi-Shemirani, Michael Chong, Nicolas Perrot, Marie Pigeyre, Gregory R. Steinberg, Guillaume Paré, Joan C. Krepinsky, Matthew B. Lanktree
medRxiv 2021.10.07.21264710; doi: https://doi.org/10.1101/2021.10.07.21264710
ATP-citrate lyase as a therapeutic target in chronic kidney disease: a Mendelian Randomization analysis
Pedrum Mohammadi-Shemirani, Michael Chong, Nicolas Perrot, Marie Pigeyre, Gregory R. Steinberg, Guillaume Paré, Joan C. Krepinsky, Matthew B. Lanktree
medRxiv 2021.10.07.21264710; doi: https://doi.org/10.1101/2021.10.07.21264710
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2317)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11653)
- Forensic Medicine (10)
- Gastroenterology (687)
- Genetic and Genomic Medicine (3655)
- Geriatric Medicine (344)
- Health Economics (625)
- Health Informatics (2340)
- Health Policy (922)
- Hematology (337)
- HIV/AIDS (765)
- Medical Education (362)
- Medical Ethics (102)
- Nephrology (394)
- Neurology (3406)
- Nursing (193)
- Nutrition (512)
- Oncology (1787)
- Ophthalmology (529)
- Orthopedics (212)
- Otolaryngology (284)
- Pain Medicine (227)
- Palliative Medicine (66)
- Pathology (442)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6046)
- Radiology and Imaging (1243)
- Respiratory Medicine (816)
- Rheumatology (373)
- Sports Medicine (319)
- Surgery (391)
- Toxicology (50)
- Transplantation (171)
- Urology (144)